1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Global Market Study on Sleep Aids: Sleep Apnea to Witness Highest Growth by 2020

Global Market Study on Sleep Aids: Sleep Apnea to Witness Highest Growth by 2020

  • August 2016
  • -
  • Persistence Market Research
  • -
  • 101 pages

Summary

Table of Contents

Sleep aids are pills and medical devices which enable a person suffering from sleep disorder to fall asleep. They are used for diagnosis and treatment of sleep disorders and sleep disturbances. Sleep disorders adversely affect human health and, in turn, drive demand for sleep aids. Major signs and symptoms of sleep disorders include irregular breathing or excessive daytime sleepiness, increased movement during sleep, and abnormal sleep behaviors. Sleep disorders have a severe effect on the neural efficiency of patients and may lead to accidents, poor health, relationship stress, and reduced productivity at work. Moreover, it can lead to various chronic diseases such as diabetes, cardiovascular diseases, obesity, and depression.

North America dominates the global sleep Aids market. The U.S. represents the largest market for sleep aids in North America. This is due to rising incidence of sleep disorders due to growing geriatric population, increasing demand for sleeping pills due to stressful modern lifestyle and rising initiatives by various health organization to increase awareness about sleep disorders in the country. Asia is expected to experience high growth rate over the next five years in the global sleep aids market.

Factors such as side effects associated with sleep aids medications and patent expiration of major sleep drugs are key restraints for the growth of the global sleep aids market.

This report provides in-depth analysis and estimation of the sleep aids market for the period 2014–2020, considering 2013 as the base year for calculation. Data pertaining to current market dynamics, including market drivers, restraints, trends, and strategic developments has been provided in the report. The global sleep aids market is categorized on the basis of sleep disorder, product, medication, and geography. On the basis of sleep disorder, the sleep aids market comprises insomnia, sleep apnea, restless legs syndrome, narcolepsy and sleep walking. On the basis of product, the market is segmented into mattresses and pillows, sleep laboratories, medications and sleep apnea devices.

In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia, and Rest of the World (RoW). North America is further segmented into the U.S. and Rest of North America. Similarly, Europe is further segmented into Germany, France, U.K., and Rest of Europe. Asia is further segmented into China, Japan and Rest of Asia.

Some of the major players in the sleep aids market are Sanofi, Merck & Co., Pfizer, Koninklijke Philips N.V. (Philips), GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Care Fusion Corporation, Teva Pharmaceutical Industries Ltd. Cadwell, SleepMed, Inc, Natus Medical manufactures, DeVilbiss Healthcare LLC and Compumedics Limited.

These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Sleep Disorder Treatment Drugs Markets in China

Sleep Disorder Treatment Drugs Markets in China

  • $ 4000
  • Industry report
  • January 2017
  • by Asia Market Information & Development Company

China’s demand for Sleep Disorder Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high ...

Global Snoring Control Devices Market 2017-2021

Global Snoring Control Devices Market 2017-2021

  • $ 3500
  • Industry report
  • March 2017
  • by Infiniti Research Limited

About Snoring Control Devices Snoring is the vibration of the respiratory channel in the human body that results in the generation of sound due to obstructed air movement during breathing in the sleep. ...

Sleep Aids In Saudi Arabia

December 2016 $ 912

Download Unlimited Documents from Trusted Public Sources

Sleep Aid Industry in India

  • February 2017
    12 pages
  • Sleep Aid  

    Therapy  

    Antihypertensiv...  

  • India  

View report >

OTC Markets in the US

  • January 2017
    12 pages
  • OTC  

  • United States  

View report >

Sleep Aid Forecast in Australia and the US

  • December 2016
    2 pages
  • Sleep Aid  

  • Australia  

    United States  

View report >

Otc Markets In The Us

9 months ago

Therapy Market In The Us

12 months ago

Related Market Segments :

Sleep Aid

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.